TR201904215T4 - Bakteriyel yapay kromozomlar. - Google Patents
Bakteriyel yapay kromozomlar. Download PDFInfo
- Publication number
- TR201904215T4 TR201904215T4 TR2019/04215T TR201904215T TR201904215T4 TR 201904215 T4 TR201904215 T4 TR 201904215T4 TR 2019/04215 T TR2019/04215 T TR 2019/04215T TR 201904215 T TR201904215 T TR 201904215T TR 201904215 T4 TR201904215 T4 TR 201904215T4
- Authority
- TR
- Turkey
- Prior art keywords
- bac
- bacterial artificial
- viral
- cdna
- bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/69—Increasing the copy number of the vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1307528.8A GB201307528D0 (en) | 2013-04-26 | 2013-04-26 | Bacterial artificial chromosomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201904215T4 true TR201904215T4 (tr) | 2019-04-22 |
Family
ID=48626864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/04215T TR201904215T4 (tr) | 2013-04-26 | 2014-04-25 | Bakteriyel yapay kromozomlar. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US10076564B2 (enExample) |
| EP (2) | EP2989205B1 (enExample) |
| JP (1) | JP6501756B2 (enExample) |
| KR (1) | KR102170609B1 (enExample) |
| CN (2) | CN105229153A (enExample) |
| AU (1) | AU2014259354B2 (enExample) |
| BR (1) | BR112015026531B1 (enExample) |
| DK (1) | DK2989205T3 (enExample) |
| ES (1) | ES2718187T3 (enExample) |
| GB (1) | GB201307528D0 (enExample) |
| HU (1) | HUE042886T2 (enExample) |
| PL (1) | PL2989205T3 (enExample) |
| PT (1) | PT2989205T (enExample) |
| SI (1) | SI2989205T1 (enExample) |
| TR (1) | TR201904215T4 (enExample) |
| WO (1) | WO2014174078A1 (enExample) |
| ZA (1) | ZA201507795B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201716254D0 (en) | 2017-10-05 | 2017-11-22 | Univ Leuven Kath | Live-attenuated flaviruses with heterologous antigens |
| GB201716307D0 (en) | 2017-10-05 | 2017-11-22 | Univ Leuven Kath | Chimeric yellow fever zika virus strain |
| WO2019204654A1 (en) * | 2018-04-18 | 2019-10-24 | Utah State University | Compositions and methods for zika virus characterization and vaccine development |
| GB201814563D0 (en) | 2018-09-07 | 2018-10-24 | Univ Leuven Kath | Chimeric flavivirus lyssavirus vaccines |
| MX2021012424A (es) | 2019-04-10 | 2022-02-10 | Univ Leuven Kath | Virus quimérico de zika-encefalitis japonesa. |
| BR112022004378A2 (pt) | 2019-09-13 | 2022-06-07 | Univ Leuven Kath | Vacinas para vírus lassa |
| WO2021048003A1 (en) | 2019-09-13 | 2021-03-18 | Katholieke Universiteit Leuven | Chimeric filovirus vaccines |
| MX2022003627A (es) * | 2019-09-25 | 2022-07-21 | Univ Leuven Kath | Vectores grandes y metodos para produccion con alto rendimiento. |
| AU2021225362A1 (en) * | 2020-02-27 | 2022-09-15 | Katholieke Universiteit Leuven | Coronavirus vaccines |
| WO2025012350A1 (en) * | 2023-07-11 | 2025-01-16 | Virovet Nv | Vectors expressing attenuated rna virus of the family arteriviridae and uses thereof |
| WO2025171062A1 (en) * | 2024-02-06 | 2025-08-14 | The Regents Of The University Of California | iMODULON GENE CLUSTERS AND METHODS TO IDENTIFY AND USE SAME |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5665600A (en) | 1991-09-18 | 1997-09-09 | Research Corporation Technologies, Inc. | Pichia pastoris linear plasmids and DNA fragments thereof |
| US5866404A (en) | 1995-12-06 | 1999-02-02 | Yale University | Yeast-bacteria shuttle vector |
| US6962708B1 (en) * | 1997-02-28 | 2005-11-08 | Acambis, Inc. | Chimeric flavivirus vaccines |
| US5874259A (en) * | 1997-11-21 | 1999-02-23 | Wisconsin Alumni Research Foundation | Conditionally amplifiable BAC vector |
| WO2000034497A2 (en) | 1998-12-09 | 2000-06-15 | The General Hospital Corporation | Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors |
| ES2170622B1 (es) | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
| GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
| US6472177B1 (en) | 2001-04-23 | 2002-10-29 | Wisconsin Alumni Research Foundation | Expression vector with dual control of replication and transcription |
| US6864087B2 (en) * | 2001-07-31 | 2005-03-08 | Wisconsin Alumni Research Foundation | Method for converting single-copy BAC vectors to conditional high-copy pBAC/oriHC vectors |
| US20050106733A1 (en) | 2001-12-25 | 2005-05-19 | Kenzo Takada | Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome |
| WO2004033633A2 (en) | 2002-10-04 | 2004-04-22 | Embiosis Pharmaceuticals | Compatible host/vector systems for expression of dna |
| US20070036827A1 (en) | 2003-10-29 | 2007-02-15 | The University Of Queensland | West nile virus vaccine |
| US20050214838A1 (en) | 2004-03-10 | 2005-09-29 | Waclaw Szybalski | Methods for mapping and sequencing nucleic acids |
| WO2009053988A1 (en) | 2007-10-25 | 2009-04-30 | Ramot At Tel-Aviv University Ltd. | Production of bac vectors carrying viral genomes |
| CN101864442A (zh) | 2010-05-19 | 2010-10-20 | 江苏省农业科学院 | 重组火鸡疱疹病毒细菌人工染色体转移载体 |
-
2013
- 2013-04-26 GB GBGB1307528.8A patent/GB201307528D0/en not_active Ceased
-
2014
- 2014-04-25 CN CN201480023688.3A patent/CN105229153A/zh active Pending
- 2014-04-25 PL PL14724009T patent/PL2989205T3/pl unknown
- 2014-04-25 JP JP2016509489A patent/JP6501756B2/ja active Active
- 2014-04-25 EP EP14724009.7A patent/EP2989205B1/en active Active
- 2014-04-25 DK DK14724009.7T patent/DK2989205T3/en active
- 2014-04-25 ES ES14724009T patent/ES2718187T3/es active Active
- 2014-04-25 BR BR112015026531-6A patent/BR112015026531B1/pt active IP Right Grant
- 2014-04-25 AU AU2014259354A patent/AU2014259354B2/en active Active
- 2014-04-25 CN CN202510130019.6A patent/CN120249337A/zh active Pending
- 2014-04-25 EP EP18215987.1A patent/EP3540065A1/en not_active Withdrawn
- 2014-04-25 SI SI201431153T patent/SI2989205T1/sl unknown
- 2014-04-25 US US14/787,098 patent/US10076564B2/en active Active
- 2014-04-25 KR KR1020157033335A patent/KR102170609B1/ko active Active
- 2014-04-25 HU HUE14724009A patent/HUE042886T2/hu unknown
- 2014-04-25 WO PCT/EP2014/058459 patent/WO2014174078A1/en not_active Ceased
- 2014-04-25 TR TR2019/04215T patent/TR201904215T4/tr unknown
- 2014-04-25 PT PT14724009T patent/PT2989205T/pt unknown
-
2015
- 2015-10-19 ZA ZA2015/07795A patent/ZA201507795B/en unknown
-
2018
- 2018-09-17 US US16/132,862 patent/US20190111125A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3540065A1 (en) | 2019-09-18 |
| SI2989205T1 (sl) | 2019-05-31 |
| AU2014259354B2 (en) | 2020-02-27 |
| ES2718187T3 (es) | 2019-06-28 |
| GB201307528D0 (en) | 2013-06-12 |
| EP2989205A1 (en) | 2016-03-02 |
| US20160206723A1 (en) | 2016-07-21 |
| CN105229153A (zh) | 2016-01-06 |
| US10076564B2 (en) | 2018-09-18 |
| BR112015026531A2 (enExample) | 2017-09-05 |
| WO2014174078A1 (en) | 2014-10-30 |
| CN120249337A (zh) | 2025-07-04 |
| EP2989205B1 (en) | 2019-01-02 |
| KR102170609B1 (ko) | 2020-10-28 |
| HUE042886T2 (hu) | 2019-07-29 |
| JP2016518132A (ja) | 2016-06-23 |
| PL2989205T3 (pl) | 2019-06-28 |
| ZA201507795B (en) | 2019-07-31 |
| AU2014259354A1 (en) | 2015-11-05 |
| BR112015026531B1 (pt) | 2023-02-07 |
| KR20160003032A (ko) | 2016-01-08 |
| US20190111125A1 (en) | 2019-04-18 |
| JP6501756B2 (ja) | 2019-04-17 |
| DK2989205T3 (en) | 2019-04-23 |
| PT2989205T (pt) | 2019-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201904215T4 (tr) | Bakteriyel yapay kromozomlar. | |
| Ando et al. | A safeguard system for induced pluripotent stem cell-derived rejuvenated T cell therapy | |
| Yu et al. | Simultaneous knockout of CXCR4 and CCR5 genes in CD4+ T cells via CRISPR/Cas9 confers resistance to both X4-and R5-tropic human immunodeficiency virus type 1 infection | |
| Chen et al. | Potential application of the CRISPR/Cas9 system against herpesvirus infections | |
| Vojtechova et al. | The role of miRNAs in virus-mediated oncogenesis | |
| Malouli et al. | Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy | |
| Barmania et al. | CC chemokine receptor type five (CCR5): An emerging target for the control of HIV infection | |
| Herd et al. | Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice | |
| CY1122654T1 (el) | Ενωσεις για βελτιωμενη iiκη μεταγωγη | |
| HRP20211015T1 (hr) | Cjepivo protiv citomegalovirusa (cmv) | |
| Miller et al. | Broad and temperature independent replication potential of filoviruses on cells derived from old and new world bat species | |
| DK2608806T3 (da) | Epstein-barr-virusvaccine | |
| UA112768C2 (uk) | Європейський штам prrsv | |
| UA108902C2 (uk) | Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування | |
| Souquette et al. | Past life and future effects—how heterologous infections alter immunity to influenza viruses | |
| Olejnik et al. | Recent advances in marburgvirus research | |
| AR069885A1 (es) | Metodos para producir el virus de estomatitis vesicular (vsv) atenuado en un cultivo celular y para mejorar el empaque del vsv de propagacion defectuosa, composicion inmunogenica, celula aislada y secuencia de control transcripcional | |
| Sircy et al. | Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection | |
| Sanghvi et al. | A re-examination of global suppression of RNA interference by HIV-1 | |
| Aerts et al. | Effect of in vitro syncytium formation on the severity of human metapneumovirus disease in a murine model | |
| Hazini et al. | Application route and immune status of the host determine safety and oncolytic activity of oncolytic coxsackievirus b3 variant pd-h | |
| JP2012125257A5 (enExample) | ||
| EA200701695A1 (ru) | Рнк вирусы с ослабленной способностью к репликации в качестве вакцин | |
| Münz | Natural killer cell responses during human γ-herpesvirus infections | |
| Gonzalez et al. | Expanding the bat toolbox: Carollia perspicillata bat cell lines and reagents enable the characterization of viral susceptibility and innate immune responses |